Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
Patents for A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics (179,784)
11/1996
11/14/1996WO1996035692A1 Antibacterial cephalosporins
11/14/1996WO1996035691A1 Spirocyclic and bicyclic diazinyl and carbazinyl oxazolidinones
11/14/1996WO1996035687A1 Peptidyl compounds and their therapeutic use
11/14/1996WO1996035681A1 Benzothiazoles and benzoxazoles, as well as drugs containing them, their use and methods of preparing them
11/14/1996WO1996035678A1 Alpha-substituted pyrimidine-thioalkyl and alkylether compounds as inhibitors of viral reverse transcriptase
11/14/1996WO1996035677A1 Nitric oxide synthase inhibitors derived from cyclic amidines
11/14/1996WO1996035467A1 Coarse spray delivery of functional biologic materials
11/14/1996WO1996035445A1 The use of epidermal growth factor as a gastrointestinal therapeutic agent
11/14/1996WO1996035440A1 Pharmaceutical composition comprising lactobacillus plantarum and arginine
11/14/1996WO1996035436A1 Compositions comprising bismuth and one or more antimicrobials, for the treatment and prevention of gastrointestinal disorders
11/14/1996WO1996035434A1 Laryngeal bactericidal and antiseptic composition
11/14/1996WO1996035423A1 Antifungal composition
11/14/1996WO1996031186A3 Product and method for preventing respiratory virus infection
11/14/1996WO1996024378A3 Delivery of exogenous compounds
11/14/1996DE19517532A1 HBV-Vektoren und Zellen zu ihrer Bereitstellung HBV vectors and cells to their provision
11/14/1996DE19517448A1 Neue Benzothiazole und Benzoxazole, diese Verbindungen enthaltende Arzneimittel und deren Verwendung sowie Verfahren zu ihrer Herstellung New benzothiazoles and benzoxazoles, pharmaceutical compositions containing them and their use, and processes for their preparation
11/14/1996CA2220910A1 Hbv vectors and cells for producing the same
11/14/1996CA2220771A1 Antibiotics
11/14/1996CA2220576A1 Combinatorial synthesis and high-throughput screening of a rev-inhibiting arylidenediamide array
11/14/1996CA2220508A1 Saccharopeptides and derivatives thereof
11/14/1996CA2220498A1 Pharmaceutical composition comprising lactobacillus plantarum and arginine
11/14/1996CA2220472A1 Genetically treated animals
11/14/1996CA2219973A1 Peptidyl compounds and their therapeutic use
11/14/1996CA2219758A1 Compositions comprising bismuth and one or more antimicrobials, for the treatment and prevention of gastrointestinal disorders
11/14/1996CA2218916A1 Dialkyltiacumicin compounds
11/14/1996CA2218879A1 Coarse spray delivery of functional biologic materials
11/14/1996CA2218360A1 Nitric oxide synthase inhibitors derived from cyclic amidines
11/14/1996CA2218088A1 Spirocyclic and bicyclic diazinyl and carbazinyl oxazolidinones
11/14/1996CA2217860A1 Benzothiazoles and benzoxazoles, pharmaceutical compositions containing these compounds and their use and processes for preparing them
11/14/1996CA2217859A1 Peptidyl compounds which inhibit metalloproteinase and tnf liberation and their therapeutic use
11/14/1996CA2217857A1 Peptide compounds which inhibit metalloproteinase and tnf liberation and their therapeutic uses
11/14/1996CA2217850A1 Peptide compounds which inhibit metalloproteinase and tnf liberation, and their therapeutic use
11/13/1996EP0742229A2 Induction of protection against viral infection
11/13/1996EP0742215A1 Cillianon, antibiotic from penicillin spe., and chemical derivatives thereof, method for their preparation and application
11/13/1996EP0742009A2 Compounds active against bacteria, mycoses and viruses
11/13/1996EP0742004A2 Substances effective against bacteria, mycosis and viruses
11/13/1996EP0741792A1 Herpesvirus pre-(viral dna replication) enveloped
11/13/1996EP0741787A1 Mammalian expression systems for hepatitis c virus envelope genes
11/13/1996EP0741786A1 Vaccine compositions comprising live bacterial vectors for protection against yersinia pestis injection
11/13/1996EP0741784A1 Ligand (act-4-l) to a receptor on the surface of activated cd4?+ t-cells
11/13/1996EP0741745A1 Hepatitis b vaccine
11/13/1996EP0741741A1 Modified oligonucleotides
11/13/1996EP0741737A1 Watersoluble azole antifungals
11/13/1996EP0741728A1 Improved process for synthesizing carbapenem intermediates
11/13/1996EP0741719A1 Intermediate and process for making
11/13/1996EP0741712A1 Process for making hiv protease inhibitors
11/13/1996EP0741578A1 Human growth hormone
11/13/1996EP0741577A1 The use of interferon subtypes in the preparation of medicaments to treat viral infections
11/13/1996EP0741575A1 Human therapeutic uses of bpi protein products
11/13/1996EP0741573A1 Use of diesters of muramyl peptides in oral form as immunostimulating agents
11/13/1996EP0741570A1 Method for preventing or reducing photosensitivity and/or phototoxicity reactions to medications
11/13/1996EP0357673B1 Antibiotic reuterin
11/13/1996CN1135756A Ganglioside GM3 analog Having sialic acid residue fluorinated at the 9-position and intermediate thereof
11/13/1996CN1135752A Easters of substituted-hydroxyacetyl piperazine phenyl oxazolidinones
11/13/1996CN1135715A Novel composition
11/13/1996CN1135483A Quinoxaline and preparation method and application thereof
11/13/1996CN1033273C New erythromycin derivatives their preparation process and their use as medicaments
11/12/1996US5574161 7-(aminomethyl-oxa-7-aza-bicyclo[3.3.0]oct-7-yl)quinolonecarboxylic and 7-(aminomethyl-oxa-7-aza-bicyclo[3.3.0]oct-7-yl naphthyridonecarboxylic acid derivatives
11/12/1996US5574153 Bactericides
11/12/1996US5574149 Method of treating HIV infections with 2',3'-dideoxy-3'-fluoro-5-chlorouridine
11/12/1996US5574132 Peptides and mixtures thereof for detecting antibodies to hepatitis C virus (HCV)
11/12/1996US5574039 Antitumor, fungicides
11/12/1996US5573786 Preparation for skin and mucous membrane
11/12/1996CA2042534C Treatment and/or a method of treating
11/12/1996CA1338706C Monoclonal anti-human breast cancer antibodies suitable for imaging breast cancer
11/12/1996CA1338705C Vaccines obtained from antigenic gene products of recombinant genes
11/12/1996CA1338703C Pharmaceutical composition for inhibiting infection with virus causative of acquired human immunodeficiency syndrome
11/07/1996WO1996034970A1 Improved methods for transfecting t cells
11/07/1996WO1996034960A1 High molecular weight major outer membrane protein of moraxella
11/07/1996WO1996034956A1 Methods for modulating t cell survival by modulating bcl-xl protein level
11/07/1996WO1996034893A1 Hybrid molecules between heat-labile enterotoxin and cholera toxin b subunits
11/07/1996WO1996034891A1 Human chemokine beta-8, chemokine beta-1 and macrophage inflammatory protein-4
11/07/1996WO1996034886A1 Compositions and methods for detecting and treating acquired immunodeficiency syndrome
11/07/1996WO1996034883A1 Acellular pertussis vaccines and methods of preparation thereof
11/07/1996WO1996034869A1 Esters of carbapenems
11/07/1996WO1996034868A1 Esters of carbapenems
11/07/1996WO1996034852A1 Novel tetracycline derivatives
11/07/1996WO1996034631A1 Method for introducing and expressing genes in animal cells
11/07/1996WO1996034625A1 Recombinant vesiculoviruses and their uses
11/07/1996WO1996034623A1 Acellular pertussis vaccines and methods of preparation thereof
11/07/1996WO1996034616A1 Serum preparations for inhibiting retroviruses and tumor growth
11/07/1996WO1996034605A1 Composition comprising amoxycillin and clavulanic acid
11/07/1996WO1996030520A3 Synthetic hpv6/11 hybrid l1 dna encoding human papillomavirus type 11 l1 protein
11/07/1996WO1996027664A3 Antisense transcript expressed in b lymphocytes and synthetic oligonucleotides useful to inhibit the activity thereof
11/07/1996WO1996015241A3 A polynucleotide tuberculosis vaccine
11/07/1996CA2433502A1 Acellular pertussis vaccines and methods of preparation thereof
11/07/1996CA2220123A1 Human chemokine beta-8, chemokine beta-1 and macrophage inflammatory protein-4
11/07/1996CA2219994A1 Method for introducing and expressing genes in animal cells
11/07/1996CA2219899A1 Shark serum preparations for inhibiting retroviruses and tumor growth
11/07/1996CA2219889A1 High molecular weight major outer membrane protein of moraxella
11/07/1996CA2219277A1 Novel tetracycline derivatives
11/07/1996CA2217990A1 Esters of carbapenems
11/07/1996CA2217885A1 Esters of carbapenems
11/06/1996EP0741128A2 Sulphuric acid esters of sugar alcohols for the inhibition of the migration and proliferation of smooth muscle cells of the vascular walls
11/06/1996EP0740937A2 Use of retinoids for the manufacture of a pharmaceutical or cosmetic composition
11/06/1996EP0740707A1 Secretion of proteins from the outer membrane of gram-negative bacteria by gram-positive host organisms
11/06/1996EP0740704A1 Immunization by inoculation of dna transcription unit
11/06/1996EP0740703A1 Diagnosis and treatment of infections due to streptococci and enterococci
11/06/1996EP0740667A1 Process and intermediates for preparing naphthyridonecarboxylic acid salts
11/06/1996EP0740653A1 Hydroxamic acid derivatives as metalloproteinase inhibitors
1 ... 1600 1601 1602 1603 1604 1605 1606 1607 1608 1609 1610 1611 1612 1613 1614 1615 1616 1617 1618 1619 1620 ... 1798